Technology

Update: iSpecimen ISPC Bottom or Fake out?

iSpecimen ISPC ran over 200% after our alert on November 22nd but as expected after an epic run like that, it will pull back. Since that 200% gain, ISPC has retraced to $5.39 just $.50 higher than what is was trading before the November explosion. It is official iSpecimen has fully retraced and could be ready for it’s next move up.

However, before you read this insightful information, sign up below, let’s stay in contact.

ISPC

iSpecimen ISPC announced last week, “the expansion of its supplier capabilities with the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research, including analyzing the Omicron and Delta variants.” However, before we get started, let’s review some basic information on this company.

iSpecimen Company Summary

Company Name:  iSpecimen

Ticker: ISPC

Exchange: NASDAQ

Website: https://www.ispecimen.com/

ISPC Company Summary

iSpecimen offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. 

LVGI News

Jan. 13, 2022

Announced the expansion of its supplier capabilities with the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research, including analyzing the Omicron and Delta variants.

The reference lab, a recent addition to the iSpecimen supplier network, has the capacity to sequence hundreds of COVID-19 positive swabs per week, providing data that is crucial in the fight against the virus. This lab is sequencing the most recent swabs to identify new variants of COVID-19 as the virus continues to progress globally.

ISPC 1 Month Chart

ispc

iSpecimen 5 Day Chart

ISPC

ISPC Technical Analysis

ISPC needs to stay above $5.43 and new highs to be a bounce. If it doesn’t, it will be a head fake! It has consolidated and appears to be slightly bullish. This could be what we have been waiting for!

Remember, to never try and catch a falling safe, or a knife for that matter. Simply let it fall to the ground, walk over, and pick up the money and walk away. If you enjoyed this article, sign up below, I promise I will never spam you and I’m pretty darn good at picking winners. Let’s make some trades together!

ISPC

read more

Breakout for Golden Star Enterprises Ltd. (OTC-GSPT)?

Golden Star Enterprises LTD is a publicly traded holding and acquisition company. (OTC:GSPT) is a tech incubator that acquires startups and takes them to the next level. 

Their extensive experience in this space and our tech industry connections, create massive opportunities for traders.

Golden Star Enterprises“Most of our subscribers are familiar with me, but for those that are new to Small Cap Exclusive’s detailed, featured, Break Out Alerts, my name is Alexander Goldman. I’ve been a trader for over 20 years and I’m pretty, pretty, pretty good at picking massive winners.”

The Company’s flagship company is Enigmai, an Israeli tech company that specializes in the Workforce Management space. I’m very excited about the results of 2021 and over the moon in 2022. You have an opportunity to get in on the ground floor, where, in my opinion, it is a steal!

The top 4 reasons Golden Star Enterprises (OTC: GSPT) is primed for a massive breakout!

#1 Enigmai’s Market Potential

#2 GSPT has great  NEWS

#3 Golden Star Enterprises (OTC: GSPT) Chart Looks Amazing!

#4 GSPT has publicly revealed an amazing strategy for 2022!

Before we go over the top 4 reasons, let’s get acquainted with Golden Star Enterprises.

Company Name: Golden Star Enterprises

Ticker: GSPT

Exchange: OTC

Website: www.goldenstarenterprisesltd.com

Company Summary:

Golden Star Enterprises LTD is a publicly traded holding and acquisition company (OTC:GSPT) is a tech incubator that acquires startups and their latest acquisition of Enigmai, an Israeli tech company, is looking very promising. 

Enigmai specializes in the Workforce Management space, as its new subsidiary. Enigmai was established in 2009 and developed a comprehensive workforce management system that enables large organizations to better manage their employees’ schedules and save money by providing a state-of-the-art management tool. 

The Workforce Management (WFM) system is critical to any organization that manages employees’ shifts. It is even more critical since many people work remotely, with employees distributed between various locations including their home office. Enigma’s offering is holistic as it offers an end-to-end solution that integrates with existing systems used by BPOs, Business Process Outsourcing otherwise known as a call center.

[thrive_leads id=’10008′]

#1 Enigmai’s Market Potential

I am intimately knowledgeable about the true market potential for this software, because I worked for five years as a consultant to Contact Centers both for customer service and sales. The lack of dependable software to forecast labor initiatives is a real problem. There is a vacuum in the marketplace that Enigmai could tap into.

There are 60,850 contact centers (with over 10 seats) in North America with 3.3 million agent positions the North American Contact center industry is valued at $28 Billion per annum. Also, 30% of that ($8.4 billion) represents outsourced activity. 

Almost one in ten Contact Centers are still using either pen and paper or whiteboards to schedule staff.

33% of the call centers are generating revenue less than 500 Million Dollars.In fact, five of the largest call centers in the US employs 40,000-47,000 employees! That is an incredible opportunity! Citation HERE

Golden Star Enterprises Ltd. - 03

If Golden Star could just capture 10% of the market that is $2.8 BILLION in revenue which would place a conservative valuation, 5X, at $10 Billion. Even if they capture 1% of the market, thats a 1 BILLION dollar valuation!

#2 GSPT has great NEWS

Nov. 10, 2021 HERE

Announced that its wholly-owned subsidiary, Enigmai Ltd, has signed a Letter Of Intent (LOI) with National Organized Workers Union to pilot its Enigmai Business Suite (EBS) workforce management system (WFM) in hospitals.

That is a huge announcement, imagine when the revenue possibly starts pouring in and they release the financials in Q1?

Jan. 06, 2022 HERE

Updated shareholders with a summary of the fiscal year 2021 activities and plans for the coming year. 2021 was a transition year for Golden Star. That means, this could be a ground floor opportunity! 

During the year, the Company focused on operations of its newly acquired Israel-based subsidiary, Enigmai Ltd., and investments in upgrades to its WorkForce Management (WFM) software product. Here are some of the activity highlights from fiscal 2021:

  • Enigmai signed three-year contracts with its existing clients
  • Enigmai was featured in a webinar in Israel, resulting in dozens of new client leads
  • GSPT established an advisory board and nominated its first two advisory board members
  • Enigmai commenced the upgrade of its WFM products’ user interface
  • Enigmai signed a pilot program for its WFM with the city of Tel-Aviv
  • Enigmai signed a contract with AuroraView, a US Based, customer-oriented software development and consulting company that offers products, solutions to take over software product support in Israel and North America
  • Enigmai participated in a major trade conference in Israel, resulting in many additional client leads
  • Enigmai signed a Letter of Intent to pilot its WFM software at some of Canada’s largest hospitals
  • The Company retained PCAOB audit firm, Pinnacle Accountancy Group (DBA Heaton & Associates) to audit fiscal 2020 and 2021 operations in order to move a step closer to becoming a fully reporting issuer with the Securities and Exchange Commission, and potentially upgrade our listing to OTCmarkets: QB

Sept. 14, 2021 HERE

Announced that its wholly-owned subsidiary, Enigmai, has signed an agreement with AuroraView, a US Based, customer-oriented software development and consulting company that offers products, solutions, and value-added services.

I’m always looking for start up incubators that are pre-revenue but showing agreements that will produce revenue in the future. So, you don’t have to chase news and get in before the morning gap ups on news.

#3 Golden Star Enterprises (OTC: GSPT) Chart Looks Amazing!

GSPT 5 Day Chart

Golde

Golden Star Enterprises 1 Day Chart

Golden Star Enterprises Ltd. - 01

GSPT Technical Analysis:

Bottom play alert, can you say that again. More importantly, you can see a clear reversal of the bearish trend in the 5 day chart. Reversal #1 and #2 is clear as day. This is exciting.

The 1 day chart clearly shows after the trend reversal a pullback as early investors liquidate the amazing 150% gains! If you look at the 1 year chart you will see, time and time again, opportunities for 100%+ winners. 

The stock is consolidating after the 150% run and is primed for a possible run. Put it on your watchlist today because GSPT might be ready to breakout to further highs soon.

#4 GSPT has publicly revealed an amazing strategy for 2022! HERE

We expect fiscal 2022 to bring the following additional accomplishments:

  • Enigmai will complete the development of the upgraded front-end client for its WFM for initial installation with existing clients
  • Enigmai will commence the WFM software pilot program with several hospitals in Canada
  • Conclude 2021 and 2020 audit of our financial results, and complete a registration statement to become a fully reporting issuer with the SEC
  • Commence development of the mobile application for Enigmai’s WFM software system
  • Commence marketing and sales activities in North America

Let’s recap why GSPT could be, THE massive breakout of 2022!

#1 Enigmai’s Market Potential

#2 GSPT has great  NEWS

#3 Golden Star Enterprises (OTC: GSPT) Chart Looks Amazing!

#4 GSPT has publicly revealed an amazing strategy for 2022!

It is a rare opportunity in this world to have this kind of investment opportunity. This company is operating in a tech sector that is exploding,  has favorable news, the chart is keen for a massive move possibly and the 2022 outlook is fundamentally solid.

Happy Trading and remember, never try to catch a falling knife!

[thrive_leads id=’10008′]

Disclaimer

Small Cap Exclusive is owned and operated by JBN PARTNERS LLC, which is a US based corporation. We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (this “Article”) about publicly traded companies (the “Profiled Issuers”).

We publish the Information on our website, smallcapexclusive.com/ and in newsletters, text message alerts, audio services, live interviews, featured “research” reports, on message boards and in email communications for specific time periods that are agreed upon between us and the Profiled Issuer and / or third party paying us. Our publication of the Information is known as a “Campaign”. This information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart. Typically, the trading volume and price of a Profiled Issuer’s securities increases after the information is provided to the first group of investors. Therefore, the later an investor receives the Information, the more likely it is that he will suffer trading losses if they purchase the securities of a Profiled Issuer late in a Campaign. We are paid to advertise the Profiled Issuers, GSPT. Small Cap Exclusive has been hired by Awareness Consulting for a period beginning on January 18, 2021 to publicly disseminate information about (GSPT) via website and email. We have been compensated $5,000 USD. We will update any changes to our compensation.

Read full disclaimer here.

read more
Reviva Pharma RVPH down big.

Reviva Pharma RVPH down big.

Reviva Pharma RVPH down big on massive volume, to find out why take a look at this technical analysis by our Alexander Goldman down below

Reviva Pharmaceuticals RVPH Company Summary

Company Name:  Reviva Pharmaceuticals Holdings, Inc.

Ticker: RVPH

Exchange: NASDAQ

Website: https://ir.revivapharma.com/

Reviva Pharmaceutical Company Summary

Reviva Pharma RVPH is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families.

Also, Reviva’s current pipeline focuses on the central nervous system, respiratory and metabolic diseases. Reviva’s pipeline currently includes two drug candidates, RP5063 (brilaroxazine) and RP1208.

Therefore, Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both RP5063 and RP1208 in the United States (U.S.), Europe, and several other countries.

Why did RVPH go down?

Jan. 10th 2021

Reviva Pharma RVPH announced today the U.S. Food and Drug Administration (FDA) has notified the Company that it may proceed with Phase 3 clinical investigation of its lead candidate, brilaroxazine, a novel serotonin and dopamine receptor modulator for the treatment of schizophrenia.

RVPH 3 Month Chart

PSTI

RVPH 1 Day Chart

PSTI

RVPH Technical Analysis

Reviva Pharmaceutical is looking bad, real bad. Don’t put it on your watchlist. It’s bearish all the way around.

read more
Pluristem Therapeutics PSTI Collaboration

Pluristem Therapeutics PSTI Collaboration

Pluristem Therapeutics PSTI signs a massive collaboration deal. Also, the stock looks great. Take a look below.

Pluristem Therapeutics PSTI Company Summary

Company Name:  Pluristem Therapeutics Inc.

Ticker: PSTI

Exchange: NASDAQ

Website: https://www.pluristem.com/  

Pluristem Therapeutics Company Summary

Pluristem is pushing the boundaries of science and engineering to create cell-based products for commercial use. The Company’s cell therapies advance the field of regenerative medicine, with potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation.

Moreover, pluristem Therapeutics’ sources its therapeutic cells from the placenta, an ethically accepted and potent source.

The Company’s manufacturing platform is a patented and validated state-of-the-art 3D cell expansion system. Pluristem’s method is uniquely accurate, cost-effective, and consistent from batch to batch.

Why did PSTI go up?

Jan. 10th 2021

Announced the launch of an innovative collaboration to develop, manufacture and commercialize cultured cell-based products for the food industry.

Therefore, the collaboration started with the incorporation of a new company (“NewCo”), that will receive exclusive, global, royalty bearing licensing rights to use Pluristem’s proprietary technology, intellectual property and knowhow, to be used in the field of cultured meat.

PSTI 3 Month Chart

Pluristem Therapeutics PSTI

PSTI 1 Day Chart

Pluristem Therapeutics PSTI

PSTI Technical Analysis

The $1.87 PPS for Pluristem Therapeutics PSTI is important before I would consider the trade. However, this stock is looking great! It gapped up big and pulled back for a minute and consolidated all day with a bullish lean.

Pluristem Therapeutics PSTI is possibly a winner, but I wouldn’t expect big things, probably sub 50% gains in the next few weeks.

read more
Zynga ZNGA purchased for $12B

Zynga ZNGA purchased for $12B

Zynga ZNGA purchased for $12B by Take-Two Interactive. ZNGA gaps up 46% with heavy trading volume this morning. Let’s take a closer look at Zynga.

Zynga Inc. ZNGA Company Summary

Company Name: Zynga Inc.

Ticker: ZNGA

Exchange: NASDAQ

Website: www.zynga.com 

[thrive_leads id=’9825′]

Zynga Inc. ZNGA Company Summary

Zynga ZNGA is a global leader in interactive entertainment with a mission to connect the world through games.

Therefore with it’s massive global reach in more than 175 countries and regions, Zynga has a diverse portfolio of popular game franchises that have been downloaded more than four billion times. Just on mobile including CSR Racing™, Empires & Puzzles™, FarmVille™, Golf Rival, Hair Challenge™, Harry Potter: Puzzles & Spells™, High Heels!, Dragons!™, Merge Magic!™, Toon Blast™, Toy Blast™, Words With Friends™ and Zynga Poker™.

With Chartboost, a leading mobile advertising and monetization platform, Zynga is an industry-leading next-generation platform with the ability to optimize programmatic advertising and yields at scale.

Founded in 2007, Zynga is headquartered in California with locations in North America, Europe and Asia.

Why did ZNGA go up over 40% overnight?

Jan. 10th 2021

Take-Two to acquire all the outstanding shares of Zynga for a total value of $9.861 per share – $3.50 in cash and $6.361 in shares of Take-Two common stock, implying an enterprise value of $12.7 billion.

Transaction represents a 64% premium to Zynga’s closing share price on January 7, 2022.

Establishes Take-Two as one of the largest publishers of mobile games, the fastest-growing segment of the interactive entertainment industry.

Unifies highly complementary businesses, including Take-Two’s best-in-class portfolio of console and PC games and Zynga’s industry-leading mobile franchises.

Creates one of the largest publicly traded interactive entertainment companies in the world, with $6.1 billion in trailing twelve-month pro-forma Net Bookings for the period ended September 30, 2021.

Consequently, Transaction expected to deliver approximately $100 million of annual cost synergies within the first two years after closing, and more than $500 million of annual Net Bookings opportunities over time.

Take-Two TTWO Company Summary

Company Name:  Take-Two Interactive Software, Inc.

Ticker: TTWO

Exchange: NASDAQ

Website: https://www.take2games.com/

Zynga Inc. ZNGA Company Summary

Headquartered in New York City, Take-Two Interactive Software, Inc. is a leading developer, publisher, and marketer of interactive entertainment for consumers around the globe.

We develop and publish products principally through Rockstar Games, 2K, Private Division, and T2 Mobile Games.

Take-Two TTWO products are designed for console systems, personal computers, and mobile, including smartphones and tablets.

Also, they deliver through physical retail, digital download, online platforms, and cloud streaming services. Take-Two TTWO common stock trades on NASDAQ under the symbol TTWO.

ZNGA 3 Month Chart

Zynga Inc. ZNGA

Zynga ZNGA 1 Day Chart

Zynga Inc. ZNGA

ZNGA Technical Analysis

After the announcement that Take-Two TTWO was acquiring Zynga Inc. ZNGA the stock gapped up with heavy trading volume by over 40%! Meanwhile TTWO suffers in PPS with a massive sell off.

ZNGA is shockingly consolidating after the massive run with a slight pullback. This is a good sign. Therefore, I would like to see it break $8.70 then $8.76 before I would take a position because normally there will be a massive sell off after a huge gap up like this.

[thrive_leads id=’9825′]

read more
Netlist NLST is ready to take off?

Netlist NLST is ready to take off?

Netlist NLST is ready to take off is a loaded question and it depends on a few factors. However, before we get into the details of whether it can be profitable in 2022, let’s take a look at a quick overview to get you familiar.

Company Name: Netlist, Inc.

Ticker: NLST

Exchange: OTC

Website: www.netlist.com

Netlist NLST company summary:

Netlist provides high-performance solid state drives and modular memory solutions to enterprise customers in diverse industries. The Company’s NVMe™ SSDs in various capacities and form factors and the line of custom and specialty memory products bring industry-leading performance to server and storage appliance customers and cloud service providers.

Netlist licenses its portfolio of intellectual property including patents, in server memory, hybrid memory and storage class memory, to companies that implement Netlist’s technology. 

Netlist NLST in the news:

In October 2021 the Court issued summary judgment in favor of Netlist and against Samsung for material breach of various obligations under the Joint Development and License Agreement (JDLA), which the parties executed in November 2015.

In the summary judgment Order, the Court also held that Netlist properly terminated the JDLA, a remedy which leaves Samsung without a license to Netlist’s patents. That ruling, however, limited the damages phase of the case to issues of direct damages. The case now moves to the post-trial phase over the next couple of months.

Netlist, Inc. 1 Month Chart

Netlist, Inc. 5 Day Chart

Netlist, Inc. NLST Technical Analysis

I like NLST if it can break $6.60 and maintain a consolidation pattern above that PPS.

It has reversed it’s bearish trend but it could be a head fake it has difficulty at the $6.60 PPS. Trade with stop losses.

read more
TAL Education Group Analysis

TAL Education Group Analysis

TAL Education Group bounces from here? Let’s take a close look.

Company Name: TAL Education Group TAL

Ticker: TAL

Exchange: NYSE

Website: https://en.100tal.com/

Company Summary:

Tomorrow Advancing Life (NYSE: TAL) is an educational technology company dedicated to supporting public and private education across the world and exploring new education models for the future with smart education tools and open platforms featuring well-rounded development and extracurricular learning.

Tal News

Bloomberg states, “Chinese companies listed in the U.S. rebounded Thursday after a five-day slump as investors piled back into stocks hurt by Beijing’s crackdown this year.

The Nasdaq Golden Dragon China Index jumped as much as 10%, its biggest intraday gain since at least 2012, putting the gauge on pace for its largest climb since 2008. Alibaba Group Holding, Tal Education Group and Vipshop Holdings Ltd. were among some of the best performers Thursday with each rallying at least 9.7%. The article can be found HERE

Also, Investors Observer released news two days ago in regards to “TAL Education Group (TAL) is around the top of the Education & Training Services industry according to InvestorsObserver. TAL received an overall rating of 42, which means that it scores higher than 42 percent of all stocks.

TAL Education Group also achieved a score of 73 in the Education & Training Services industry, putting it above 73 percent of Education & Training Services stocks. Education & Training Services is ranked 125 out of the 148 industries.” The article can be found HERE

TAL 6 month chart

TAL Education Group TAL 5 day chart

Tomorrow Advancing Life (NYSE: TAL) 1 day chart

Tomorrow Advancing Life (NYSE: TAL) Technical Analysis:

TAL is a very interesting play. If you look at the overall Chinese sector it is a very good time to invest in Chinese stocks. The government announced tax incentives that should bolster the strength of the publicly traded companies.

A technical analysis in the 6 month chart shows that this is most definitely a bottom play.

The 5 day chart reveals that the trend has reversed but is showing difficulty with a double confirmation at the $4.00 PPS. The 1 day chart shows a strong bullish move and then consolidation with an end of the day slight bearish move to be watched.

Overall, I like the stock! My only concern in the short term is a bearish break from the consolidation pattern. If I was to invest in this company, I would once it breaks $4.00 with ease.

read more
Reliance Global Group RELI is very bullish

Reliance Global Group RELI is very bullish

Let’s take a quick bird’s eye view of Reliance Global Group RELI and why RELI is up over 200% in less than two weeks. Before we get started, let’s go over the particulars.

Company Name: Reliance Global Group

Ticker: RELI

Exchange: NASDAQWebsite: https://www.relianceglobalgroup.com/

Reliance Global Group Company Summary:

Reliance Global Group, Inc. (NASDAQ: RELI, RELIW) is combining advanced technologies, with the personalized experience of a traditional insurance agency model.

Also, Reliance Global Group’s growth strategy includes both an organic expansion as well as acquiring well managed, undervalued and cash flow positive insurance agencies.

Why did it go up over 200%?

Reliance Global Group RELI announced a private placement of preferred stock, common stock and warrants for gross proceeds of $20.0 million before deducting the placement agent’s fees and other estimated offering expenses.

The offering is expected to close on or around December 27, 2021.

Reliance Global Group RELI 1 Day Chart:

RELI technical analysis

I expect it to consolidate in between $6.13 & $6.36 before the next move. I’m feeling good about this stock and believe with the big news and the overall bullish trend in the 5 day and 1 day that it is a stock to watch carefully! 

If the stock falls below $6.13, that is an indicator of a pullback so be careful!

read more